iBio Balance Sheet Health
Financial Health criteria checks 3/6
iBio has a total shareholder equity of $9.2M and total debt of $13.1M, which brings its debt-to-equity ratio to 142.8%. Its total assets and total liabilities are $34.0M and $24.8M respectively.
Key information
142.8%
Debt to equity ratio
US$13.14m
Debt
Interest coverage ratio | n/a |
Cash | US$2.79m |
Equity | US$9.20m |
Total liabilities | US$24.83m |
Total assets | US$34.02m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: IBIO's short term assets ($19.7M) do not cover its short term liabilities ($21.6M).
Long Term Liabilities: IBIO's short term assets ($19.7M) exceed its long term liabilities ($3.3M).
Debt to Equity History and Analysis
Debt Level: IBIO's net debt to equity ratio (112.5%) is considered high.
Reducing Debt: IBIO's debt to equity ratio has increased from 0% to 142.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: IBIO has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: IBIO is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.